Antibody Therapy Market
According to Intent Market Research, the Antibody Therapy Market is expected to grow from USD 83.5 Billion in 2023 at a CAGR of 11.3% to touch USD 176.3 Billion by 2030. The Antibody Therapy Market is dominated by key players such as AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celltrion Healthcare, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Regeneron Pharmaceuticals and Sanofi.